Pharmaceutical Manufacturing of Bupivacaine/Epinephrine Injection

The contract involves the production of Bupivacaine Hydrochloride 0.5% combined with Epinephrine 0.005 mg/ml, formulated in 1.8 mL cartridges. The manufacturing process must adhere strictly to FDA Good Manufacturing Practices (GMP) as well as specific military medical standards, ensuring the product meets both civilian regulatory requirements and the unique specifications necessary for military use. This pharmaceutical manufacturing subcontract is managed under the Department of Defense’s Medical Supply Chain Pharmacy FSA, highlighting its strategic importance for military medical readiness. The solicitation was posted on May 18, 2026, with a response deadline set for May 26, 2026. The contract falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The place of performance is listed as FPO, with the associated ZIP code 96662, indicating a likely overseas or military postal facility. The contract does not specify any set-aside provisions or detailed organizational types but is focused on subcontracting opportunities within the pharmaceutical production sector to fulfill medical supply needs for defense-related operations.